MoonLake downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlyMoonLake downgraded to Peer Perform from Outperform at Wolfe Research
25d ago
MoonLake Immunotherapeutics reports Q2 EPS (39c), consensus (28c)
Premium
The Fly
MoonLake Immunotherapeutics reports Q2 EPS (39c), consensus (28c)
1M ago
MoonLake Immunotherapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
MoonLake Immunotherapeutics initiated with an Outperform at Oppenheimer
3M ago
MoonLake Immunotherapeutics announces anticipated events
PremiumThe FlyMoonLake Immunotherapeutics announces anticipated events
5M ago
MoonLake Immunotherapeutics reports Q1 EPS (22c), consensus (19c)
Premium
The Fly
MoonLake Immunotherapeutics reports Q1 EPS (22c), consensus (19c)
5M ago
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
Premium
Press Releases
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
5M ago
MoonLake Immunotherapeutics initiated with a Neutral at Goldman Sachs
PremiumThe FlyMoonLake Immunotherapeutics initiated with a Neutral at Goldman Sachs
6M ago
Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush
Premium
The Fly
Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush
6M ago
3 Best Stocks to Buy Now, 3/14/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 3/14/2024, According to Top Analysts 
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100